Select Page

Sapphire Biotech

Sapphire Biotech, Inc. is dedicated to improving lives around the world through advancing global cancer care with innovative research and discovery methods.

 

Click the link below to learn about the latest research using
Sapphire’s Rapid Diagnostic Test.

Learn More

Our 
mission

Our mission is to improve global cancer care through the development of novel Therapeutics for inhibiting metastatic cancer growth, Diagnostic for early cancer detection, response to treatment, and recurrence monitoring.

Early Cancer Detection

QSOX1, a unique enzyme elevated in cancer patients can be detected earlier than circulating tumor cells.

Response to Treatment

Sapphire Biotech’s lead compound has shown to significantly reduce tumors in under 20 days.

Innovative Research

Sapphire’s expert scientists are commited to development of novel diagnostic for early detection and treatment.

Dedicated to Changing Lives Through Research

Sapphire Biotech has identified a unique enzyme, Quiescin Sulfhydryl Oxidase 1 (QSOX1), which is elevated in cancer patients and can be detected earlier than circulating tumor cells. The company’s development of QSOX1 as a unique cancer biomarker has led it to important discoveries based on testing hundreds of human samples. Sapphire’s lead compound has been tested in animal studies has shown to significantly reduce tumors by two-thirds in under 20 days.

Global Demand and Growing Market Potential

With the oversight and expertise of internationally-recognized scientists and medical experts, Sapphire Biotech not only has great potential to help hundreds of millions of cancer patients throughout the U.S., but also become a strategic asset for its investors. The global cancer therapy market is experiencing a strong growth pattern with a CAGR over the next four years of 8.37% and 90% of cancer patients dying from metastatic cancer. Sapphire’s team has developed never-before-seen and proven compounds to combat metastatic cancer.

$136.2 Billion

2018 Global Cancer Therapy Market Value

$220.7 Billion

Estimated Global Cancer Therapy Market Value by 2024

90%

Of cancer deaths are caused by metastatic cancer

Reach Us

Sapphire Biotech, Inc.

6191 Cornerstone Court, E., Suite 114
San Diego, CA 92121

info@sapphirebiotech.com

Leave A Message